- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產(chǎn)品
- 聯(lián)系我們
別名: Barbasco, Dactinol, Paraderil, Rotenon, Rotocide 中文名稱:魚藤酮
Rotenone是一種植物殺蟲劑,是線粒體電子傳遞mitochondrial electron transport的抑制劑。Rotenone 可抑制 NADH/DB oxidoreductase 和 NADH oxidase,對應的IC50值分別為28.8 nM和5.1 nM。Rotenone 可通過增強線粒體活性氧的產(chǎn)生來誘導凋亡。Rotenone 可用于誘導帕金森病動物模型。
Rotenone Chemical Structure
CAS: 83-79-4
相關(guān)靶點 | NOX1 NOX4 NOX2 | 點擊展開 |
---|---|---|
相關(guān)產(chǎn)品 | Setanaxib (GKT137831) DPI (Diphenyleneiodonium chloride) VAS2870 GSK2795039 GLX351322 2-Acetylphenothiazine (ML171) | 點擊展開 |
相關(guān)化合物庫 | 激酶抑制劑庫 FDA藥物庫 天然產(chǎn)物庫 已知活性藥物庫-I 高選擇性抑制劑庫 | 點擊展開 |
細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息 |
---|---|---|---|---|---|
MG63 | Function assay | 1 uM | 1 hr | Increase in lactate production in MG63 cells at 1 uM after 1 hr by ELISA | 17088489 |
N548 | Activation of AKT in | 10 uM | 6 hrs | Activation of AKT in DNA-deficient rat striatal neuronal N548 mutant cells at 10 uM after 6 hrs by Western blotting | 17726098 |
N548 | Cell death rescue assay | 10 uM | 7 days | Cell death rescue in rat striatal neuronal N548 mutant cells analysed every day for 7 days at 10 uM by trypan blue dye-exclusion assay | 17726098 |
T47D | Function assay | 0.01 to 0.1 uM | 72 hrs | Reduction in ATP level in human T47D cells at 0.01 to 0.1 uM after 72 hrs by HPLC-UV analysis | 21875114 |
T47D | Function assay | 0.1 to 1 uM | 30 mins | Inhibition of mTOR in human T47D cells assessed as eIF2alpha hyperphosphorylation on Ser 51 at 0.1 to 1 uM after 30 mins by Western blotting | 21875114 |
T47D | Function assay | 0.1 to 1 uM | 30 mins | Inhibition of mTOR in human T47D cells assessed as eEF2 hyperphosphorylation on Ser 56 at 0.1 to 1 uM after 30 mins by Western blotting | 21875114 |
MDA-MB-231 | Function assay | 0.1 to 1 uM | 30 mins | Inhibition of mTOR in human MDA-MB-231 cells assessed as eIF2alpha hyperphosphorylation on Ser 51 at 0.1 to 1 uM after 30 mins by Western blotting | 21875114 |
MDA-MB-231 | Function assay | 0.1 to 1 uM | 30 mins | Inhibition of mTOR in human MDA-MB-231 cells assessed as eEF2 hyperphosphorylation on Ser 56 at 0.1 to 1 uM after 30 mins by Western blotting | 21875114 |
MDA-MB-231 | Function assay | 0.01 to 0.1 uM | 48 hrs | Reduction in ATP level in human MDA-MB-231 cells at 0.01 to 0.1 uM after 48 hrs by HPLC-UV analysis | 21875114 |
N548 | Activation of ERK in | 10 uM | Activation of ERK in rat striatal neuronal N548 mutant cells at 10 uM by Western blotting | 17726098 | |
N548 | Activation of AKT in | 10 uM | Activation of AKT in rat striatal neuronal N548 mutant cells at 10 uM by Western blotting | 17726098 | |
N548 | Activation of ERK in | 50 uM | Activation of ERK in rat striatal neuronal N548 mutant cells at 50 uM by Western blotting | 17726098 | |
N548 | Activation of AKT in | 50 uM | Activation of AKT in rat striatal neuronal N548 mutant cells at 50 uM by Western blotting | 17726098 | |
N548 | Cell death rescue assay | 10 uM | Cell death rescue in DNA-deficient rat striatal neuronal N548 mutant cells at 10 uM | 17726098 | |
T47D | Function assay | 0.001 to 0.1 uM | Inhibition of cellular respiration in human T47D cells assessed as rate of oxygen consumption at 0.001 to 0.1 uM | 21875114 | |
TA3/Ha | Function assay | 12 uM | Induction of NAD(P)H oxidation in mouse TA3/Ha cells assessed as reduction of NAD(P)H/NAD(P)+ ratio at 12 uM by spectrofluorometer analysis | 24568614 | |
U937 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human U937 cells after 72 hrs by WST-8 assay, IC50=0.07μM | 17158054 | |
U937 | Antiproliferative assay | 48 hrs | Antiproliferative activity against human U937 cells after 48 hrs by WST-8 assay, IC50=0.2μM | 17158054 | |
U937 | Antiproliferative assay | 24 hrs | Antiproliferative activity against human U937 cells after 24 hrs by WST-8 assay, IC50=13μM | 17158054 | |
HepG2 | Antitumor assay | 24 hrs | Antitumor activity against human HepG2 cells after 24 hrs by MTT assay, ED50=15μM | 17482824 | |
A549 | Antitumor assay | 24 hrs | Antitumor activity against human A549 cells after 24 hrs by MTT assay, ED50=26μM | 17482824 | |
U373 MG | Antiproliferative assay | 72 hrs | Antiproliferative activity against human U373 MG cells after 72 hrs | 18513974 | |
T47D | Function assay | 48 hrs | Reduction in ATP level in human T47D cells after 48 hrs by HPLC-UV analysis | 21875114 | |
697 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human 697 cells after 72 hrs by MTS assay, IC50=0.3μM | 23895019 | |
697 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human 697 cells after 48 hrs by MTS assay, IC50=0.3μM | 23895019 | |
HT-29 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human HT-29 cells after 72 hrs by SRB assay, IC50=0.3μM | 23895019 | |
Raji | Cytotoxicity assay | 72 hrs | Cytotoxicity against human Raji cells after 72 hrs by MTS assay, IC50=1.1μM | 23895019 | |
Raji | Cytotoxicity assay | 48 hrs | Cytotoxicity against human Raji cells after 48 hrs by MTS assay, IC50=4.2μM | 23895019 | |
HepG2 | Cytotoxicity assay | 24 hrs | Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay, IC50=1.52μM | 30613327 | |
HEK293 | Function assay | Effect on cofilin1 expressed in HEK293 cells assessed as effect on cofilin1; Limk2 interaction complexes in presence of camptothecin by EYFP and/or YFP Venus fragment based reporter gene assay | 16680159 | ||
HEK293 | Function assay | Inhibition of of c-Jun expressed in HEK293 cells assessed as induction of protein interaction in presence of camptothecin with Pin1 by EYFP based reporter gene assay | 16680159 | ||
HEK293 | Function assay | Effect on p53 expressed in HEK293 cells assessed as effect on p53-p53 interaction complexes in presence of camptothecin by EYFP and/or YFP Venus fragment based reporter gene assay | 16680159 | ||
HEK293 | Function assay | Effect on Cdc2 expressed in HEK293 cells assessed as effect on Cdc2:Cdc25A interaction complexes in presence of camptothecin by EYFP and/or YFP Venus fragment based reporter gene assay | 16680159 | ||
HEK293 | Function assay | Effect on Cdc2 expressed in HEK293 cells assessed as effect on Cdc2:Cdc25C interaction complexes in presence of camptothecin by EYFP and/or YFP Venus fragment based reporter gene assay | 16680159 | ||
HT1080 | Function assay | Inhibition of proMMP2 production in human HT1080 cells by gelatin zymography analysis | 17158054 | ||
HT1080 | Function assay | Inhibition of proMMP9 production in human HT1080 cells by gelatin zymography analysis | 17158054 | ||
neural precursor cells | Function assay | Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay | 17417631 | ||
N548 | Cell death rescue assay | Cell death rescue in rat striatal neuron N548 mutant cells, EC50=0.5μM | 17726098 | ||
ASH neuronal cells | Cell death rescue assay | Cell death rescue of ASH neuronal cells in Caenorhabditis elegans Huntington's disease model, EC50=2μM | 17726098 | ||
neuronal cells | Cell death rescue assay | Cell death rescue of neuronal cells in drosophila Huntington's disease model, EC50=10μM | 17726098 | ||
N548 | Toxicity assay | Toxicity in rat striatal neuronal N548 mutant cells, TC50=40μM | 17726098 | ||
N548 | Cell death rescue assay | Suppression of cell death in rat striatal neuronal N548 mutant cells assessed as suppression of caspase 7 activation by Western blotting | 17726098 | ||
N548 | Cell death rescue assay | Cell death rescue in rat striatal neuronal N548 mutant cells by calcein acetoxymethyl ester assay | 17726098 | ||
N548 | Cell death rescue assay | Suppression of cell death in rat striatal neuronal N548 mutant cells assessed as suppression of caspase 3 activation by Western blotting | 17726098 | ||
Hepa-1c1c7 | Cytotoxicity assay | Cytotoxicity against mouse Hepa-1c1c7 cells, IC50=0.7μM | 23895019 | ||
Hepa1c1c7 | Function assay | Induction of quinone reductase in mouse Hepa1c1c7 cells, CD=0.8μM | 23895019 | ||
L5178Y | Cytotoxicity assay | Cytotoxicity against mouse L5178Y cells by MTT assay, IC50=0.3μM | 28075580 | ||
TC32 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells | 29435139 | ||
DAOY | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells | 29435139 | ||
SJ-GBM2 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells | 29435139 | ||
A673 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells | 29435139 | ||
SK-N-MC | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells | 29435139 | ||
BT-37 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells | 29435139 | ||
NB-EBc1 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells | 29435139 | ||
Saos-2 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells | 29435139 | ||
LAN-5 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells | 29435139 | ||
BT-12 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells | 29435139 | ||
OHS-50 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells | 29435139 | ||
Rh41 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells | 29435139 | ||
A673 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for A673 cells) | 29435139 | ||
SK-N-MC | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SK-N-MC cells | 29435139 | ||
BT-12 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for BT-12 cells | 29435139 | ||
LAN-5 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for LAN-5 cells | 29435139 | ||
NB-EBc1 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for NB-EBc1 cells | 29435139 | ||
BT-37 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for BT-37 cells | 29435139 | ||
TC32 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for TC32 cells | 29435139 | ||
MG 63 (6-TG R) | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for MG 63 (6-TG R) cells | 29435139 | ||
fibroblast cells | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for control Hh wild type fibroblast cells | 29435139 | ||
OHS-50 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for OHS-50 cells | 29435139 | ||
DLD1 | Function assay | Inhibition of mitochondrial oxidative phosphorylation in human DLD1 cells assessed as reduction in oxygen consumption rate by seahorse XFe96 analyser based assay | 31774672 | ||
點擊查看更多細胞系數(shù)據(jù) |
產(chǎn)品描述 | Rotenone是一種植物殺蟲劑,是線粒體電子傳遞mitochondrial electron transport的抑制劑。Rotenone 可抑制 NADH/DB oxidoreductase 和 NADH oxidase,對應的IC50值分別為28.8 nM和5.1 nM。Rotenone 可通過增強線粒體活性氧的產(chǎn)生來誘導凋亡。Rotenone 可用于誘導帕金森病動物模型。 |
---|
分子量 | 394.42 | 分子式 | C23H22O6 |
CAS號 | 83-79-4 | SDF | Download Rotenone SDF |
儲存條件(自收到貨起) | |||
體外溶解度 |
DMSO : 40 mg/mL ( (101.41 mM) ;DMSO吸濕會降低化合物溶解度,請使用新開封DMSO) Water : Insoluble Ethanol : Insoluble |
摩爾濃度計算器 |
體內(nèi)溶解度 現(xiàn)配現(xiàn)用,請按從左到右的順序依次添加,澄清后再加入下一溶劑 |
動物體內(nèi)配方計算器 |
動物體內(nèi)配方計算器(澄清溶液)
第一步:請輸入基本實驗信息(考慮到實驗過程中的損耗,建議多配一只動物的藥量)
第二步:請輸入動物體內(nèi)配方組成(配方適用于不溶于水的藥物;不同批次藥物配方比例不同,請聯(lián)系Selleck為您提供正確的澄清溶液配方)
計算結(jié)果:
工作液濃度: mg/ml;
DMSO母液配制方法: mg 藥物溶于μL DMSO溶液(母液濃度mg/mL,注:如該濃度超過該批次藥物DMSO溶解度,請先聯(lián)系Selleck);
體內(nèi)配方配制方法:取μL DMSO母液,加入μL PEG300,混勻澄清后加入μL Tween 80,混勻澄清后加入μL ddH2O,混勻澄清。
體內(nèi)配方配制方法:取μL DMSO母液,加入μL Corn oil,混勻澄清。
注意:1. 首先保證母液是澄清的;
2.一定要按照順序依次將溶劑加入,進行下一步操作之前必須保證上一步操作得到的是澄清的溶液,可采用渦旋、超聲或水浴加熱等物理方法助溶。
在訂購、運輸、儲存和使用我們的產(chǎn)品的任何階段,您遇到的任何問題,均可以通過撥打我們的熱線電話400-668-6834,或者技術(shù)支持郵箱tech@selleck.cn,直接聯(lián)系到我們。我們會在24小時內(nèi)盡快聯(lián)系您。
如果有其他問題,請給我們留言。
* 必填項